The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM) (OTEST)
The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes: OTEST
Sponsor: Duke-NUS Graduate Medical School
Terminated
Unable to reach the target recruitment within timeline
Other terminated trials from Duke-NUS Graduate Medical School
Listed as NCT01510847, this PHASE4 trial focuses on Assess the Effects of a the 90-day Oral TS Study Regimen on PSA, IPSS, Haemoglobin and Haematocrit, and to Assess Adverse and Serious Adverse Events. and remains terminated or withdrawn. Sponsored by Duke-NUS Graduate Medical School, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Duke-NUS Graduate Medical School
- Singapore Clinical Research Institute
- Singapore General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .